Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer: a systematic review and meta-analysis

Overview of attention for article published in BMC Cancer, October 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 100 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

ASSAYS FOR FIXED DOSE COMBINATIONS

Application WO-2022013189-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.